Mechanistically, GBM tumour cell kynurenine production activates the aryl hydrocarbon receptor (AHR) on TAMs, decreasing NFKβ signalling and thereby promoting an M2-like phenotype, leading to cytotoxic CD8+ T cell dysfunction [275]. Here, CD8A is linked to neoplasm.